Treatment of gastroesophageal reflux disease with autonomic dystonia syndrome with combination of proton pump inhibitor Rabeprazole and neuroleptic sulpiride
https://doi.org/10.31146/1682-8658-ecg-179-7-92-95
Abstract
According to the results of the study in the main group of patients who received complex treatment (IPP and neuroleptic), there was a significant positive dynamics of the main clinical manifestations, compared with the control group. All patients reported a significant decrease in the intensity of heartburn and pain.
The use of probulin with vegetative-corrective action in the complex treatment of patients with GERD with vegetative dystonia syndrome allowed to more effectively stop the painful manifestations and reduce the emotional experience of bodily discomfort, improve the emotional state and mental health of patients, as well as improve their quality of life.
About the Author
F. I. Khamrabaeva
Tashkent Institute of Postgraduate Medical Education
Uzbekistan
Uzbekistan
Feruza I. Khamrabaeva - Doctor of Medical Sciences, professor, head of the Department of Gastroenterology and Physiotherapy, Dean of the Faculty of Medicine.
10007, Tashkent, st. Parkentskaya 51.
References
1. Veselova E. N. The place of prosulpine (sulpiride) in the treatment of psychosomatic pathology. South Ros. med. Journal, 2000, No. 5-6, pp. 86-88.
2. Ivashkin V. T., Trukhmanov A. S. Program treatment of gastroesophageal reflux disease in the daily practice of a doctor. Ros. journal gastroenterol., hepatol., coloproctol. 2013, No. 6, pp. 18-27.
3. Minushkin O. N., Ivashkin V. T., Trukhmanov A. S. et al. Pariet in Russia: results of a multicenter clinical trial. Ros. journal gastroenterol., hepatol., coloproctol. 2000, Vol. 10, No. 6, pp. 43-46.
4. Trukhmanov A. S., Kardasheva S. S., Ivashkin V. T. The experience of using parity in the treatment and prevention of relapse of gastroesophageal reflux disease. Grew up. journal gastroenterol., hepatol., coloproctol. 2012, vol. 12, No. 4, pp. 73-79.
5. Shapovalova M. M. Study of the quality of life of patients with gastroesophageal reflux disease in combination with coronary heart disease and treatment optimization issues: Author. dis. . cand. med. sciences. V., 2007, 23P.
6. Besanson M., Simon A., Sachs A., Shin J. M. Sites of reaction of the gastric H+, K+ - ATPase with extracytoplasmic thiol reagents. J. boil. Chem. 2007, Vol. 272, pp. 22438-22446.
7. Gardner J. D., Slaan S., Barth J. B. Rabeprazole vs. Omeprazole: oncet., duration and magnitude of antisecretory effects. United European Gastroenterology Week, Brussel. 2011, P. 43.
8. Hetzel D. Acid pump inhibitors. The treatment of gastroesophageal reflux. Aust. Fam. Physiacian. 2008, Vol. 6, pp. 487-491.
9. Kulig M., Leodolter A., Vieth M. et al. Quality of life in relation to symptoms in patients with gastroesophageal reflux disease - on analysis based on the Pro GERD initiative. Aliment. Pharmacol. Ther. 2003, Vol. 18, pp. 767-776.
10. Pounder R. Studies with rabeprazole involunteers. Satellite Symposium “Rabeprazole - way ahead in acid control”. World Congress of Gastroenterology. Vienna, Austria. 2009.
Review
For citations:
Khamrabaeva F.I. Treatment of gastroesophageal reflux disease with autonomic dystonia syndrome with combination of proton pump inhibitor Rabeprazole and neuroleptic sulpiride. Experimental and Clinical Gastroenterology. 2020;(7):92-95. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-179-7-92-95
Views:
702
Email this article 